The Human Microbiome Symposium was held at EMBL in Heidelberg.
The following MyNewGut partner presentations were given during the event:
The key objective of the Summit is to explore how to tackle all forms of malnutrition by increasing the availability and affordability of safe and nutritious foods for all on a sustainable basis. The MyNewGut project coordinator Dr Yolanda Sanz of the Spanish National Research Council (CSIC) particpated in the workshop.
Download the programme booklet here.
MyNewGut partners Nathalie Delzenne (UCL), Peter Holzer (University of Graz), Patrizia Brigidi (University of Bologna) and Max Nieuwdorp (University of Amsterdam) will take part in the next Symposium on Hormones and Cell Regulation organized by the European Society of Edocrinology.
This symposium will deal with the interactions between the brain, the gut and the microbiome as a crucial network involved in metabolic regulation, obesity, type 2 diabetes and neurodegenerative disorders. The main topics to be covered will be:
Consult with the Programme here.
EUFIC, together with all partners of the MyNewGut project, is organising a final conference to present the results of this five-year EU funded project and provide an input on how the human gut microbiota and its genome (microbiome) influence obesity, behavioural - and lifestyle-related disorders.
The MyNewGut project – which falls under the European Union’s Seventh Framework Programme, - brings together 30 partners from 15 different countries and aimed to identify specific dietary strategies to improve the long-term health of the population.
Why is it relevant for research and innovation?
Emerging evidence indicates that the gut microbiome contributes to our ability to extract energy from the diet and influences development and function of the immune, endocrine and nervous systems, which regulate energy balance and behaviour. This has led to hypothesize that developing microbiome-based dietary interventions can be cost-effective measures to prevent diet-related and behavioural disorders.
The conference will take place on 18 October 2018 at Stanhope Hotel, Rue de Commerce 9, B-1000 Brussels at 9 and will open with a session chaired by Isabelle de Froidmont-Görtz from DG Research & Innovation of the European Commission.